Pulsenmore Ltd

Pulsenmore Ltd(PLSM)股票分析

$1.510

-0.039 (-2.57%)收盘时

Loading chart…
最高
1.610
开盘
1.610
成交量加权均价
1.51
成交量
6.64K
市值
—
最低
1.420
成交额
10.04K
企业价值/息税折旧摊销前利润(TTM)
0.00

Pulsenmore Ltd is an Israel-based medical equipment company. The Company engaged in the field of research and development activity, production, marketing and sales worldwide of solutions and technologies that concern portable ultrasound devices for home use by the patient for a remote physical examination or monitoring using telehealth technology. he company has developed and sells two miniaturized ultrasound systems: the first is called PulseNmore ES, for performing home ultrasound tests for pregnant women; and the second is called PulseNmore FC, for performing a self-test of the size of the follicles in women who are in the process in vitro fertilization. Both systems make use of a smart mobile phone and make the test accessible without the need o visit in clinic or hospital, while being able to transfer film for the doctor, the treating medical team or the hotline online. Moreover the COmpany delivers software for its products.

AI 分析 of Pulsenmore Ltd (PLSM)

卖出

Pulsenmore Ltd is not a good buy right now. The current price is $1.51, which is significantly down 84.02% year-to-date. The RSI is at 25.769, indicating that the stock is oversold, but this could also suggest continued weakness. The forward P/E ratio is 0, reflecting uncertainty in future earnings, and the stock has a 52-week high of $12.97, showing a large gap from the current price. The main risk is the negative sentiment reflected in the 5-day change of -9.57% and the ongoing volatility in the stock's performance.

估值指标

Pulsenmore Ltd(PLSM)当前预期市盈率为 0.00,5 年平均预期市盈率为 。

预期市盈率

5 年均值 P/E
当前P/E
0.00

预期 EV/EBITDA

5 年均值 EV/EBITDA
当前EV/EBITDA
0.00

预期市销率

5 年均值 P/S
当前P/S
0.00

持有 PLSM 的大户

A

Aquamarine Financial (Cayman) Ltd

+ 持有PLSM

+0.03%

3个月收益率

事件时间线

2026-10-13 (ET)

07:30:00

Pulsenmore Appoints David Woods as Chief Commercial Officer

2026-09-17 (ET)

07:30:00

Pulsenmore Completes Registration of Pulsenmore FC

2026-08-31 (ET)

16:30:00

Major Averages Decline as September Rate Hike Probability Rises to 60%

12:00:00

Major Averages Broadly Lower as Oil Prices Rise

07:30:00

Pulsenmore Reports 1H Revenue of $2.042M

资讯

PLSM 常见问题 —— 由 Alphio AI 解答

Pulsenmore Ltd is an Israel-based medical equipment company. The Company engaged in the field of research and development activity, production, marketing and sales worldwide of solutions and technologies that concern portable ultrasound devices for home use by the patient for a remote physical examination or monitoring using telehealth technology. he company has developed and sells two miniaturized ultrasound systems: the first is called PulseNmore ES, for performing home ultrasound tests for pregnant women; and the second is called PulseNmore FC, for performing a self-test of the size of the follicles in women who are in the process in vitro fertilization. Both systems make use of a smart mobile phone and make the test accessible without the need o visit in clinic or hospital, while being able to transfer film for the doctor, the treating medical team or the hotline online. Moreover the COmpany delivers software for its products. It operates in the Healthcare sector.

Pulsenmore Ltd is not a good buy right now. The current price is $1.51, which is significantly down 84.02% year-to-date. The RSI is at 25.769, indicating that the stock is oversold, but this could also suggest continued weakness. The forward P/E ratio is 0, reflecting uncertainty in future earnings, and the stock has a 52-week high of $12.97, showing a large gap from the current price. The main risk is the negative sentiment reflected in the 5-day change of -9.57% and the ongoing volatility in the stock's performance.

暂无帖子

注册或登录后参与讨论

相关文章

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

开始交易